Cord blood (CB) is an attractive alternative to bone marrow or peripheral blood as a source of transplantable hematopoietic tissue. However, because of the reduced volume, the stem cell content is limited; therefore its use as a graft for adult patients might require ex vivo manipulations. Two systems have been described that identify these stem cell populations in vitro in both mice and humans: (1) the long-term culture-initiating cells (LTC-IC), thus named because of their ability to support the growth of hematopoietic colonies (colony-forming cell (CFC)) for 5-6 weeks when co-cultured on stromal layers; (2) the generation of hematopoietic progenitors (CFC) from stroma-free liquid cultures for extended periods of time, which provides further indirect evidence of the presence of primitive stem cells. Both systems detect largely overlapping but not identical populations of stem cells. Thus the identification of the growth factor requirements for the maintenance and amplification of both systems is relevant. On this basis, analysis of the effects of 18 cytokine combinations on stroma-free liquid cultures of CB CD34
Introduction
Cord blood (CB), as with other hematopoietic tissues, contains a variety of hematopoietic cells, the most primitive of which Correspondence: W Piacibello, Dept. of Biomedical Sciences and Human Oncology, Clinica Medica I, Via Genova 3, 10126 Torino, Italy; Fax: 39 11 6637 238 Received 17 November 1997; accepted 23 January 1998 are characterized by an ability to generate very large numbers (Ͼ10 13 ) of all known mature blood cell types. [1] [2] [3] [4] In both mouse and human systems, a subset of extremely primitive hematopoietic cells has been identified because of its ability to generate clonogenic cells (colony-forming cells (CFC)) for at least 5 weeks on suitable stroma feeder layers of murine or human origin. 5 These long-term culture-initiating cells (LTCICs) share a number of features with long-term in vivo repopulating cells. 6 In addition, generation of CFC for extended periods of time is indirect evidence of the presence of primitive stem cells. 7, 8 Recently it has been shown that CD34 + CB cells can be grown for extremely long periods of time in liquid suspension cultures in the absence of preformed stroma layers and can generate increasingly greater numbers of CFC. The continuous generation of CFC was accompanied by a net expansion of LTC-IC, which could be amplified by a factor of 5 logs. 9 The purpose of our studies was to identify specific growth factors or growth factor combinations that could stimulate an optimum expansion of LTC-IC in stroma-free liquid cultures initiated with CD34 + CB cells. Experiments were also carried out in order to determine how these GF requirements might compare to those needed to maximize CFC production from the same starting population.
Materials and methods

Cell sources
Bone marrow (BM) was obtained by aspiration from the posterior iliac crest of hematologically normal donors who had given informed consent. Umbilical cord blood (CB) was obtained, with informed consent, at the end of full-term pregnancies, by draining blood from the clamped and cut cord into sterile collection tubes containing the anticoagulant citrate-phosphate dextrose.
CD34
+ cell purification
Mononuclear cells (MNC) were isolated from CB using FicollHypaque (density 1077; Nyegaard, Oslo, Norway) density centrifugation. Cells were subjected to two cycles of plastic adherence (60 min each); they were then washed with Hanks' balanced salt solution (HBSS; GIBCO BRL, Grand Island, NY, USA). The CD34 + MNC fraction was isolated with superparamagnetic microbead selection using high-gradient magnetic field and miniMACS columns (Miltenyi Biotech, Gladbach, Germany).
The efficiency of the purification was verified by flow cytometry counterstaining with a CD34-phycoerythrin (PE; HPCA-2; Becton Dickinson, Mountain View, CA, USA) antibody. In the cell fraction containing purified cells, CD34-positive cells ranged from 89 to 94%.
Recombinant human cytokines
The following recombinant purified human cytokines were used in these studies: recombinant human (rh) stem cell factor or c-kit ligand (rhKL) and recombinant human granulocyte colony-stimulating factor (rhG-CSF) were from Genzyme (Cambridge, MA, USA); recombinant human granulocytemacrophage colony-stimulating factor (rhGM-CSF), recombinant human interleukin 6 (rhIL6) and recombinant human interleukin-3 (rhIL3) were from Sandoz (Basel, Switzerland); recombinant human erythropoietin (rhEPO, EPREX) was from Cilag (Milan, Italy); recombinant human FLT3-ligand (rhFL) was obtained from SD Lyman (Immunex Corporation, Seattle, WA, USA); recombinant human thrombopoietin (rhTPO) was obtained from DC Foster (Zymogenetics, Seattle, WA, USA).
Progenitor assays
Long-term culture-initiating cells (LTC-ICs):
BM stroma was produced by culturing 1 × 10 7 fresh BM mononuclear cells in a T 25 flask for at least 2 weeks in 5 ml stromal medium (12.5% horse serum (HS), 12.5% fetal calf serum (FCS; both from Hyclone, Logan, UT, USA), Iscove's modified Dulbecco's medium (IMDM, GIBCO BRL), 5 × 10 −5 mol/l 2-mercaptoethanol (Sigma-Aldrich, Milano, Italy), 10 −6 mol/l hydrocortisone (Sigma), and penicillin/streptomycin). One or 2 days before cocultures were produced, BM stroma was irradiated with 15 Gy and plated at 7 × 10 3 /cm 2 in 24-well tissue culture plates to form pre-established stromal layers for the long-term cultures. Limiting dilutions (10 to 1000 CD34 + CB cells) and equivalent aliquots (ie limiting dilutions) of the cells grown in long-term stroma-free cultures after 2-28 weeks, were seeded on top of the irradiated bone marrow stroma in culture medium containing IMDM, 12.5% HS, 12.5% FCS, 5 × 10 −5 mol/l 2-mercaptoethanol and 10 −6 mol/l hydrocortisone for 5 weeks at 33°C with weekly changes of half the medium. At the end of the 5-week LTC-IC assay period, non-adherent cells were removed from the cultures, combined with the corresponding trypsinized adherent cells, washed and assayed for cell colony-forming units (CFU-Cs) in methylcellulose medium containing 1.3% methylcellulose (Fluka; Chemika Biochemika, Buchs, Switzerland), 30% FCS, erythropoietin (3 U/ml), IL-3 (20 ng/ml), G-CSF (20 ng/ml), GM-CSF (20 ng/ml) and KL (50 ng/ml). These cultures were incubated at 37°C and colonies (CFU-GM, BFU-E, CFU-GEMM) were scored 2-3 weeks later. These counts provide a relative, but quantitative measure of the number of LTC-IC initially present.
Stroma-free long term cultures:
Twenty thousand CD34 + CB cells were cultured in quadruplicate flat-bottomed 24-well plates in 1 ml of IMDM supplemented with 10% FCS and the following cytokines: IL3 (10 ng/ml), IL6 (10 ng/ml), KL (50 ng/ml), FL (50 ng/ml), TPO (10 U/ml), which were added, alone or in a combination of two or more factors, to each series of microwells twice a week. The wells were grown at 37°C at 5% CO 2 . In selected experiments, 10% FCS was replaced by 10% pooled human serum (GIBCO BRL) or by serum-free substitutes: 10 20 ng/ml bovine serum albumin (BSA), 10 g/ml of human insulin, 200 g/ml human transferrin (BIT; Stem Cell Technologies, Vancouver, British Columbia, Canada) plus 40 g/ml low-density lipoproteins (LDL; Sigma Chemical). No significant differences both in LTC-IC expansion and CFC output, in the different culture conditions, were observed. When the culture was started the number of CFU-GM and CFC present in 1 ml of a single well was determined by agar and plasma-clot, 11, 12 the number of CFU-Mk by plasmaclot technique 12 and the number of BFU-E/CFU-GEMM by methylcellulose assay. 10 All the assays were performed in quadruplicate.
Every week all the wells were demi-depopulated by removal, after resuspension of the cells, of one half of the culture volume, which was replaced with fresh medium and growth factors. Cells of the harvested media were counted and suitable aliquots of the all suspensions were assayed for CFU-GM, CFC and CFU-Mk every week; for BFU-E/CFU-GEMM, for LTC-IC and for immunophenotype analysis every 2 or 3 weeks.
The total number of CFU-GM, CFC, CFU-Mk and BFU-E/CFU-GEMM present in each LTC well was determined by using the following equation: CFU-or BFU-E/ml culture = y (observed CFU-C × 2 n ) where n = the number of previous demidepopulations 12, 13 and y = the number corresponding to the fraction of 1 ml cell suspension (ie 1/62 = 15.6 l, 1/34 = 31 l) which was plated in semisolid assays.
Clonogenic assays
The clonogenic assays were performed as follows. For CFU-GM, 5 × 10 2 CD34 + CB cells of the initial cell suspension, or aliquots of the stroma-free long-term cultures, were cultured at four plates per point in 3% agar, 15% FCS in IMDM. For CFU-Mk and CFC, the same number of cells were cultured in plasma-clot assay (four dishes per point) as previously described. 9, 12 For BFU-E/CFU-GEMM, 5 × 10 2 CD34 + CB cells/dish in at least four plates per point were cultured in 1.3% methylcellulose (Fluka), 30% FCS in IMDM at 37°C in a humidified atmosphere at 5% CO 2 in air. Colony scoring was performed on day 12 for CFC and CFU-MK (the former at the inverted microscope, the latter at the immunofluorescent microscope after staining with a fluorescein isothiocyanate (FITC)-conjugated MoAb recognizing the IIbIIIa GP) and on day 14 for CFU-GM, and BFU-E/CFU-GEMM. To sustain the formation of BFU-E/CFU-GEMM, IL3 (20 ng/ml), Epo (3 U/ml) and KL (50 ng/ml) were added; for CFU-GM, G-CSF (20 ng/ml), GM-CSF (20 ng/ml), IL3 (20 ng/ml) and KL (50 ng/ml); for CFU-MK and CFC, IL3 (5 ng/ml).
Immunophenotyping by flow cytometry
After purification aliquots of CD34 + CB cells were incubated with mouse IgG (Fluka) to block non-specific binding to Fc receptors and then stained with a panel of monoclonal antibodies (FITC, or PE-conjugated CD34, CD38, CD33, CD14, (all from Becton Dickinson) and antiglycophorin (Dakopatts, Glostrup, Denmark). FITC-and PE-conjugated mouse isotype control antibodies were used for each culture.
Every 2-3 weeks aliquots of cultured cells were counted, washed and then subjected to the same procedure. The only difference was that cells were also incubated with propidium iodide (1 g/ml), to analyze only viable cells.
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Flow cytometric analysis was performed using a FACScan cytometer (Becton Dickinson). At least 10 000 events were acquired for each analysis. When the percentage of the cells was Ͻ1% the acquired events were at least 30 000.
Statistical analysis
Results are expressed as the mean ± s.e.m. Levels of significance between samples were determined using an analysis of variance and the Neuman-Keuls test.
Results
Effect of multiple growth factors on LTC-IC amplification
In previous experiments we showed that the combination of FL and TPO, in the absence of stroma, was capable of supporting a progressive production of hematopoietic progenitors from CB for over 6 months. This phenomenon was the result of a progressive amplification of primitive hematopoietic stem cells, defined as LTC-IC. 9 Therefore, we wanted to see whether other growth factor combinations could support an equal or even better expansion of primitive hematopoietic progenitors.
Short-term suspension cultures:
CD34 + CB cells were incubated for 2 weeks in liquid suspension culutres containing different combinations of growth factors in the absence of stroma, to determine the extent of LTC-IC expansion with each condition.
The factors evaluated in these experiments were FL, KL, IL3, IL6 and TPO, single or in combinations, since previous experiments demonstrated that their association would stimulate a marked amplification of primitive blast cell colony-forming units (CFU-Bl, data not shown).
A measure of the LTC-IC content of the input CD34 + cells was obtained in a limiting dilution assay (LDA), by seeding 10 to 1000 CD34 + cells onto pre-established irradiated bone marrow feeder layers and by assessing the number of CFC generated 5 weeks later. The same approach (LDA assay) was used to determine the LTC-IC content of the equivalent cells harvested from each of the different liquid cultures after 7 and 14 days.
After the first 2 weeks of liquid cultures a high LTC-IC amplification (74-fold the input number) was observed when a four-factor combination with IL6, KL, FL and TPO was used Table 1 Effects of selected culture conditions on the expansion, over time of different classes of hematopoietic progenitors ( Figure 1 ). Another important finding (see Figure 1) was that FL by itself was able to increase the number of LTC-IC significantly above the input value and to the same extent as the four-factor combination (two-fold and 73-fold after 1 and 2 weeks, respectively). Of all the other factors used singularly, TPO was able to support a limited, albeit net expansion of LTC-IC numbers. The association of KL + FL appeared capable of expanding the LTC-IC value (79-fold increase at the second week of culture). LTC-ICs were expanded 44-fold by KL + TPO). The association of FL + TPO induced a 38-fold increase of the LTC-IC pool and the addition of KL further improved the degree of expansion (47-fold).
The difference between the 7-and 14-day expansion clearly indicated that the LTC-IC pool, in the presence of certain growth factors or growth factor combinations could be further increased by extending the duration of the suspension cultures.
Long-term suspension cultures:
The ability of the same growth factors or growth factor combinations to further support an amplification of the LTC-IC compartment was evaluated after increasingly longer periods of liquid cultures. The results generated by these experiments are summarized in Figure 2a and b. The LTC-IC pool was maintained for up to 5 weeks when only FL alone was present in the suspension cultures. The association of KL + FL was also able to further maintain the expansion of the LTC-IC population, which increased by 74-fold at week 5 and was still detectable at week 9. Figure 2 clearly shows that TPO played a substantial role in determining a massive amplification of the LTC-ICs over an extended period of time. Indeed, if compared to FL or TPO alone, the addition of both factors (FL and TPO) induced a dramatic increase of the LTC-IC numbers (eg at week 5 FL induced a 12-fold amplification, while FL + TPO induced a 330-fold expansion). Furthermore, this expansion kept increasing with increasing culture time, so that at week 23 the LTC-IC content of a single culture was Ͼ270 000-fold the number of LTC-IC present in the inoculum at the start of cultures. TPO also ameliorated the effect of KL, although to a lesser extent than when added to FL (91-fold increase after 9 weeks of culture).
Similarly, TPO to KL + FL once again resulted in a massive stimulation of LTC-IC expansion over time, which reached a Ͼ100 000-fold increase after 23 weeks of culture.
On the other hand, when IL3 was added as a supplement to any of the growth factor combinations, not only was it incapable of further enhancing the already stimulated LTC-IC expansion, but it also produced a negative effect, resulting in a decrease of the LTC-IC numbers.
This was not so in the case of IL6, which appeared to be neutral, as no modifying effect on the LTC-IC output was observed.
Effects of multiple growth factors on CFC production
It has been demonstrated that the LTC-IC amplification and the production of CFC from CD34 + CD38 − BM cells show different growth factor dependence. 10, 13 Short-term cultures:
The kinetics of CFC outputs, measured during the first 2 weeks of liquid culture with the same growth factor combinations evaluated for LTC-IC are shown in Figure 3 .
Among the single growth factors tested, IL3 was the most potent stimulator of CFC output during the first 2 weeks of liquid culture (19.6 ± 0.5-fold increase). FL and KL alone supported a modest expansion of CFC output (six-and 12-fold respectively); when combined, they stimulated a 24-fold increase in CFC numbers, but this result was not further improved by the addition of IL3 or IL6.
Long-term cultures:
When the liquid cultures were extended for very long periods of time (longer than so-called 'Extended LTC' (ELTC) 7, 8 ), completely different patterns emerged (Figure 4a, b, c and d) .
The relevant figures show that, of the various growth factor
Figure 2 (a and b) Kinetics of CB LTC-IC expansion over time. Generation and expansion of primitive stem cells (identified as LTC-IC). Twenty-thousand CD34
+ CB cells were plated in quadruplicate 24-well plates in the presence of the factors reported above. The frequency of LTC-IC in the initial CD34 + CB cells (input value) was 13 ± 5/100 CD34 + cells. This was determined by limiting dilution assay by plating 10-1000 CD34
+ cells onto pre-established irradiated feeder layers from normal bone marrow and then assessing the number of CFC present 5 weeks later. Every week all the wells were demi-depopulated by removal of one half the culture volume, which was replaced with fresh medium and growth factors. At the indicated time points, cells of the harvested media were counted and suitable aliquots in limiting dilutions of the cell suspensions were assayed for LTC-IC in quadruplicate dishes. The results represent the mean ± s.e.m. of four representative experiments performed in quadruplicate.
combinations, only three were capable of supporting an increasingly greater CFC output, which kept augmenting for 30 weeks. The levels of CFC output, although massive in the three cases, were not entirely identical. In the presence of FL + TPO the CFC output was Х28 million-fold the initial number; in the presence of KL + FL + TPO it reached 109 million-fold and in the presence of IL6 + KL + FL + TPO the CFC levels were Х48 million-fold the number of CFC inoculated in each well at the beginning of the suspension cultures. A decline of the CFC production was initially seen between weeks 28 and 30 in the three cases and after week 33 hemopoietic colonies could no longer be detected.
As anticipated by the LTC-IC data, the association of KL + TPO did not sustain a particularly extended and massive hemopoietic proliferation: thus, the production of CFC was detectable for 20 weeks of suspension cultures; maximum CFC output was obtained at week 16 (Х52 000-fold).
As already observed for the LTC-IC amplification and in keeping with the findings reported above, the presence of IL3, in addition to any of the growth factor combinations employed in this study, improved neither the extent nor the persistence of CFC output, even when TPO was simultaneously present. The combination of IL3 + FL + TPO was far less potent on CFC output (maximum: 1440-fold at week 10 and no longer CFC growth at week 16. The addition of IL3 to TPO + KL + FL induced a Х6000-fold increase of CFC output by week 12 and no colonies were detectable by week 16. IL3 + KL + TPO sustained a CFC output which reached a 236-fold increase at week 8 and by week 12 CFCs were no longer detectable).
Along with the granulocyte-macrophage progenitors, also megakaryocyte, erythroid and mixed progenitors were generated and amplified during the long-term suspension cultures. The combination of FL + TPO, KL + FL + TPO or IL6 + KL + FL + TPO also sustained a marked expansion of CFU-Mk and BFU-E for up to 26 weeks of culture. As reported in Table 1 , at the beginning of the long-term suspension cultures, the growth of the megakaryocyte progenitors appeared to be most sensitive to the presence of IL3; however, the expansion of the hemopoietic progenitors in the presence of IL3 was only transient; not only CFU-Mk, but also CFU-GM and BFU-E/CFU-GEMM production disappeared quite soon. In contrast, in the absence of IL3, the combinations of FL, TPO, KL ± IL6 proved to be capable of sustaining an extremely prolonged and massive generation of hemopoietic progenitors. Table 1 also shows that the association of TPO with any of the other growth factors, single or in combination, induced increases of the CFC output. What is more, not only was the CFU-Mk output enhanced but also the CFU-GM and BFU-E/CFU-GEMM.
The CD34 expression by hematopoietic cells was main-
Figure 3
Short-term CFC expansion from CB CD34 + cells. Twenty-thousand CD34 + CB cells were incubated for 1 and 2 weeks in stromafree liquid cultures containing different cytokine combinations as shown. IL3, IL6, FL,TPO and KL were used at the concentrations indicated in Materials and methods. At weeks 1 and 2 aliquots of the cells of the harvested media were cultured in plasma-clot assays as described in Materials and methods. Mean ± s.e.m. of the fold increase number of CFC relative to the input CFC value (two to four different experiments performed in duplicate).
tained throughout the course of LTC. The CD34 + population underwent continuous expansion in the presence of certain growth factor combinations, so that each well, containing initially Х20 000 CD34 + cells, after 20 weeks of culture contained Ͼ19 × 10 9 CD34 + cells in the presence of FL, KL and TPO, 3.8 × 10 9 CD34 + cells in the presence of FL + TPO, 3.4 × 10 9 CD34 + cells in the presence of IL6, KL, FL and TPO, and 0.65 × 10 9 CD34 + cells in the presence of KL + TPO (data not shown). Table 2 also shows that, while at the beginning of the longterm cultures only 8-15% of the CD34 + cells were capable of clonal growth, after increasingly longer periods in suspension culture, a greater percentage of CD34 + cells was capable of generating colonies in semisolid medium, so that after 15 weeks of LTC, almost all the CD34 + cells were clonogenic cells.
Discussion
Characterization of culture conditions that allow human hematopoietic stem cell expansion is an important requirement for the successful implementation of many clinical transplantation and gene therapy protocols. 14, 15 These studies represent a significant step towards the practical realization of such approaches. Our experiments show that in the absence of stromal layers cord blood CD34
+ cells can be grown for over 7 months. During such a period a massive amplification of primitive hematopoietic stem cells, defined as LTC-IC, can be obtained, so that after 23 weeks of culture, an expansion of up to 270 000-fold of the initial inoculum is observed.
Previous studies demonstrated that the simple combination of two unique growth factors,FLT3-ligand and thrombopoietin, was able to elicit this phenomenon. 9 The data reported here represent an analysis of multiple growth factor requirements of very primitive stem cells in order to undergo selfrenewal processes.
After short-term (7 and 14 days) liquid cultures, the amplification of LTC-IC did not appear to differ greatly, whether FL was used alone or in combination. In similar culture conditions, CFC production did not produce significant variations, the association of 'primitive' growth factors (FL and KL) being even less efficient than others in sustaining the output of more mature hemopoietic progenitors.
FL was already known as a growth factor capable of stimulating LTC-IC maintenance 16 and amplification 17, 18 from peripheral blood CD34
+ Lin − and bone marrow CD34 + 38 − subpopulations, respectively. In our studies, FL by itself was capable of sustaining a 72-fold increase of CB LTC-IC number after 14 days of culture and this value was not significantly improved by the addition of the other growth factors studied. The amplification of LTC-IC in the presence of FL alone, much greater than that reported by other authors, could be attributable to the unique properties of CB hematopoietic progenitors, which are known to possess higher proliferative potentials than the corresponding adult progenitors. In our studies, TPO by itself also proved to be capable of amplifying the LTC-IC numbers -although to a lesser degreeconfirming recently reported data. 17 The most relevant finding that emerges from our experiments is that a completely different situation is observed when the suspension cultures are extended for prolonged periods of time. The kinetics of LTC-IC expansion demonstrated that the stem cell pool could be further expanded by increasing the length of incubation: afer a 5-week incubation only some growth factor combinations could sustain a prolonged and increasingly greater expansion of LTC-IC. After an additional 4 weeks of liquid cultures only three growth factor combinations (FL + TPO, KL + FL + TPO and IL6 + KL + FL + TPO) kept expanding the LTC-IC pool up to 23 weeks. FL and TPO were present in all GF combinations, therefore the first conclusion that can be drawn is that FL and TPO are both necessary and sufficient to sustain the LTC-IC amplification and that the presence of IL6 or KL does not seem to substantially modify the LTC-IC amplification induced by FL and TPO.
A second important issue, in our opinion, is that the presence of IL3 (alone or in addition to all the GF combinations) proved to be negative, in that the extent of LTC-IC amplification was decreased and limited to 9 weeks. The negative effect of IL3 for LTC-IC amplification could be attributed to an increased induction of proliferation and maturation of primitive stem cells at the expense of the self-renewal capacity, as recently demonstrated. [19] [20] [21] The experiments described here throw new light on the kinetics of expansion of primitive stem cells. Indeed, data reported so far on LTC-IC amplification are limited to incubation periods of a few weeks. [16] [17] [18] In our experiments, after a 2 week-incubation, the magnitude of LTC-IC expansion did not appear to be different for several growth factor combinations. However, when the same culture conditions were prolonged, quite the opposite occurred with the LTC-IC pool, in that only a few growth factor combinations could further amplify it, while others would lead to its exhaustion.
The amplification of the stem cell pool was also indirectly suggested by the data obtained by analyzing the kinetics of CFC output over extremely prolonged periods of time. During the first 10-12 weeks of culture the CFC output increased every week and no striking differences between the different growth factor combinations could be observed. However, after the 12th week, a sharp drop in CFC production, reflecting exhaustion of more immature progenitors, regularly occurred in the presence of several growth factor combinations. Conversely, only KL + TPO and IL6 + KL + FL sustained an exponential output of the CFC till the 16th week. Only the combinations containing FL + TPO, FL + KL + TPO and IL6 + KL + FL + TPO could sustain a prolonged and mass- Continued.
ive CFC output, which was well over 10 million-fold of the input number at week 25. Finally, cultures containing FL + TPO and KL + FL + TPO began to slow down at week 30 and CFC production sustained by KL + FL + TPO had completely terminated by week 32. So far, LTC systems capable of supporting human hematopoiesis for extended periods of time, without an exhaustion of primitive stem cells, are all dependent on the presence of stromal layers. Even then, the CFC output can be observed for some weeks and their amplification is obtained without a concomitant net expansion or even a maintenance of the stem cell pool. 14, 15, 17, 22, 23 The decline and disappearance of clonogenic precursors reflect the exhaustion of a more primitive cell population. The data reported here show a CFC production that increased week by week for over 30 weeks. Committed progenitors are not provided with self-renewal potential, thus the progressive amplification of the CFC pool must be sustained by progressive amplification of population(s) of primitive stem cells, capable of self-renewal capacity and great proliferative potential. The finding that the clonogenic progenitors belong to all of the myeloid lineages also strongly suggests that such primitive stem cells can follow different maturation pathways; therefore, they are multipoint stem cells.
If the LTC-IC and CFC amplifications are compared, some interesting facts can be noted. The FL + TPO combination appears to be an extremely powerful inducer of LTC-IC expansion, while KL + FL + TPO and IL6 + FL + KL + TPO appears as slightly less powerful. In contrast, maximum CFC output is sustained by the combination of IL6 + FL + KL + TPO or KL + FL + TPO. Also CFU-Mk and BFU-E/CFU-GEMM output is maximally sustained by IL6 + KL + FL + TPO and KL + FL + TPO.
The hematopoietic system is a hierarchical organization in which primitive, quiescent stem cells can undergo selfrenewal amplification and also generation of less primitive, proliferating cells, which possess a greater proliferative potential and a lesser degree of self-renewal capacity. 24, 25 The target cells of FL + TPO could then be represented by very primitive hematopoietic stem cells in which the self-renewal potential exceeds the proliferative capacity, while the target cells of KL + FL + TPO ± IL6 could reside in a compartment of early stem cells, a portion of which, probably daughter cells, possesses a lesser degree of self-renewal capacity and a much higher proliferative potential. The addition of KL ± IL6 might promote in these cells a stronger commitment towards the three maturation pathways.
The overall analysis of the data presented here allows three considerations. (1) The LTC-IC amplification observed after 2-5 weeks of suspension cultures only partially reflects the true repopulating potential of the stem cell population; in fact the fate of the stem cell pool can be quite different and strictly dependent on the growth factor combinations employed. It is also possible to speculate that, among the LTC-IC generated after 2-5 weeks of liquid cultures, different populations of stem cells exist, some of which are more primitive than the LTC-ICs themselves as recently suggested by Larochelle et al. 26 (2) Our assay might be usefully employed for the detection in vitro of a very primitive stem cell subpopulation, the characterization and quantification of which and its relationship with in vivo repopulating units, far from being satisfactory, are currently under investigation in our laboratories. (3) Finally, the findings reported here demonstrate that primitive hematopoietic cord blood stem cells can be greatly amplified in vitro under defined culture conditions and this may represent a first step towards larger scale cultures for cord blood transplantation and gene therapy.
